Welcome to our dedicated page for Elevance Health news (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health stock.
Elevance Health, Inc. (NYSE: ELV) generates a steady stream of news as a major participant in the direct health and medical insurance carriers industry. Company updates frequently focus on financial performance, member experience initiatives, digital tools, and community health programs. Investors and observers following ELV news can see how Elevance Health communicates its strategy as a lifetime, trusted health partner serving over 109 million consumers through medical, pharmacy, behavioral, clinical, home health, and complex care solutions.
News coverage often includes earnings results and guidance, such as quarterly financial releases that detail segment performance for Health Benefits and Carelon, membership trends across commercial, Medicare, Medicaid, and Federal Employee Program lines, and commentary on benefit expense ratios and operating metrics. The company also issues announcements about upcoming conference calls and webcasts where management reviews results and outlook with investors.
Another key theme in Elevance Health news is the evolution of the healthcare consumer experience. Articles describe AI-enabled digital solutions, including the Virtual Assistant available through the Sydney Health app, which helps members understand benefits, compare costs, and find in-network providers. The company also highlights care management programs, concierge-style support for serious illnesses, and models such as “My Health Advocate” in affiliated Medicare plans.
Elevance Health news frequently covers whole-health and community initiatives. Examples include Food as Medicine partnerships with the National Association of Community Health Centers, school-based fitness facility upgrades, and expanded access to doula care and social supports in certain Medicare Advantage and Medicaid plans. Governance developments, such as the appointment of independent directors to the board and related committee assignments, are also reported through press releases and SEC-linked announcements.
By reviewing the ELV news feed on this page, readers can follow financial disclosures, strategic initiatives, digital and clinical innovations, and community-focused programs that shape Elevance Health’s role in the health benefits and healthcare services landscape.
AM Best has confirmed that the Credit Ratings of Elevance Health (NYSE: ELV) and its subsidiaries remain unchanged after the announcement on January 23, 2023 regarding its acquisition of Louisiana Health Service and Indemnity Company, operating as Blue Cross and Blue Shield of Louisiana. BCBSLA serves over 1.9 million members with approximately $1.8 billion in capital. AM Best will monitor the acquisition's progress through legal and regulatory approvals, which may affect Elevance's financial leverage, projected to increase slightly beyond 40%. The acquisition is expected to be accretive to earnings and close in the second half of 2023.
Elevance Health has announced a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana (BCBSLA). This acquisition aims to enhance community health services, leveraging Elevance's advanced healthcare capabilities. BCBSLA, serving over 1.9 million members, will continue to operate from Baton Rouge and maintain its local workforce of approximately 3,000 employees. The deal, expected to close later this year, will also establish the Accelerate Louisiana Initiative, a multibillion-dollar foundation focused on health equity. The acquisition is subject to customary closing conditions and regulatory approvals.
Elevance Health (NYSE: ELV) is set to release its fourth quarter 2022 financial results on January 25, 2023, at 6:00 a.m. EST. A conference call will follow at 8:30 a.m. EST, where management will discuss the results and future outlook. Interested participants should access the call 15 minutes early, using specific phone numbers for domestic and international calls. The call will also be available via a live webcast on Elevance Health's website.
Elevance Health (NYSE: ELV) has earned full three-year accreditation for health equity from the National Committee for Quality Assurance (NCQA) for 21 of its affiliated Medicaid plans. This accreditation highlights the company's commitment to enhancing health equity and addressing the needs of historically marginalized communities. Currently, 93% of Elevance Health's Medicaid members are enrolled in accredited plans, representing a significant achievement in the industry. The company aims to innovate and improve care for diverse populations across the nation.
Elevance Health has partnered with Impact Fitness Foundation to enhance the fitness resources at Herron-Riverside High School in Indianapolis. This initiative celebrates the inaugural Elevance Health Women’s Fort Myers Tipoff basketball tournament.
The upgraded facility, unveiled on November 16, features new equipment and aims to promote health and wellness, especially for the 60% female student-athlete population. This collaboration reflects Elevance Health's commitment to health equity and improving community health resources.
Elevance Health announces its agreement to acquire BioPlus, a specialty pharmacy under CarepathRx, enhancing its specialty drug solutions for complex conditions like cancer and autoimmune diseases. This acquisition supports Elevance's whole-health strategy, aiming to improve access and reliability for clients. Post-acquisition, BioPlus will operate under IngenioRx, Elevance's pharmacy benefit manager. The deal is set to close in the first half of 2023, with no expected material impact on adjusted earnings per share this year.
Elevance Health (NYSE: ELV) will present at the 4th Annual Wolfe Research Healthcare Conference in New York City on November 16 at 10:00 a.m. EST. Stakeholders can access the live webcast by visiting Elevance Health’s website. A replay will be available for 90 days post-presentation. Elevance Health is dedicated to enhancing healthcare access for over 119 million individuals through its comprehensive portfolio of medical, digital, and behavioral health solutions.
The recent study commissioned by Elevance Health reveals that 94% of Americans who used virtual primary care are satisfied, with 79% feeling empowered about their health. Conducted by The Harris Poll, the survey of over 5,000 adults shows that convenience and accessibility are key attractions to virtual care. While 48% are familiar with the term, 73% find it appealing. Many Americans, especially those with chronic conditions, see it as a way to enhance healthcare access. The study confirms a significant rise in telehealth usage, nearly 20 times pre-pandemic levels.
Elevance Health (NYSE: ELV) will present at the 31st Annual Credit Suisse Healthcare Conference on November 9, at 11:35 a.m. PST in Rancho Palos Verdes, California. Interested individuals can access the live webcast via www.elevancehealth.com. A replay will be available for 90 days after the presentation. Elevance Health serves over 119 million people with a range of healthcare solutions, dedicated to improving health outcomes and supporting communities.
The Board of Directors of Elevance Health (NYSE: ELV) announced the appointment of Deanna Strable to the Board. With over 30 years in financial services, Strable is currently CFO of Principal Financial Group, responsible for financial integrity and growth. Her experience includes leading the U.S. Insurance Solutions division. Strable's appointment brings the board's female and diverse director representation to over 70%. Elizabeth Tallett, Board Chair, highlighted her proven expertise in the insurance sector and commitment to diversity.